These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 1965139

  • 1. Growth inhibition of a human lymphoma cell line: induction of a transforming growth factor-beta-mediated autocrine negative loop by phorbol myristate acetate.
    Sing GK, Ruscetti FW, Beckwith M, Keller JR, Ellingsworth L, Urba WJ, Longo DL.
    Cell Growth Differ; 1990 Nov; 1(11):549-57. PubMed ID: 1965139
    [Abstract] [Full Text] [Related]

  • 2. Loss of transforming growth factor beta 1 receptors and its effects on the growth of EBV-transformed human B cells.
    Kumar A, Rogers T, Maizel A, Sharma S.
    J Immunol; 1991 Aug 01; 147(3):998-1006. PubMed ID: 1713611
    [Abstract] [Full Text] [Related]

  • 3. Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta.
    Arteaga CL, Coffey RJ, Dugger TC, McCutchen CM, Moses HL, Lyons RM.
    Cell Growth Differ; 1990 Aug 01; 1(8):367-74. PubMed ID: 2177634
    [Abstract] [Full Text] [Related]

  • 4. Different signals mediate transforming growth factor-beta 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
    Franzén P, Ichijo H, Miyazono K.
    Exp Cell Res; 1993 Jul 01; 207(1):1-7. PubMed ID: 7686495
    [Abstract] [Full Text] [Related]

  • 5. Synergistic inhibition of phorbol ester-induced transformation of JB6 cells by transforming growth factor-beta and retinoic acid.
    De Benedetti F, Falk L, Ruscetti FW, Colburn NH, Faltynek CR, Oppenheim JJ.
    Cancer Res; 1991 Feb 15; 51(4):1158-64. PubMed ID: 1847657
    [Abstract] [Full Text] [Related]

  • 6. Induction of transforming growth factor beta 1 and its receptors during all-trans-retinoic acid (RA) treatment of RA-responsive human neuroblastoma cell lines.
    Cohen PS, Letterio JJ, Gaetano C, Chan J, Matsumoto K, Sporn MB, Thiele CJ.
    Cancer Res; 1995 Jun 01; 55(11):2380-6. PubMed ID: 7757990
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Further studies of the role of transforming growth factor-beta in human B cell function.
    Kehrl JH, Taylor AS, Delsing GA, Roberts AB, Sporn MB, Fauci AS.
    J Immunol; 1989 Sep 15; 143(6):1868-74. PubMed ID: 2550546
    [Abstract] [Full Text] [Related]

  • 10. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
    Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C, Kari C.
    Cancer Res; 1994 Jan 15; 54(2):575-81. PubMed ID: 8275496
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lymphoma models for B cell activation and tolerance. V. Anti-Ig mediated growth inhibition is reversed by phorbol myristate acetate but does not involve changes in cytosolic free calcium.
    Scott DW, Livnat D, Whitin J, Dillon SB, Snyderman R, Pennell CA.
    J Mol Cell Immunol; 1987 Jan 15; 3(2):109-20. PubMed ID: 3509921
    [Abstract] [Full Text] [Related]

  • 14. Effects of transforming growth factor beta on megakaryocytic cell fusion and endomitosis.
    Cowley SA, Groopman JE, Avraham H.
    Int J Cell Cloning; 1992 Jul 15; 10(4):223-31. PubMed ID: 1645030
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor I and transforming growth factor alpha as autocrine growth factors in human pancreatic cancer cell growth.
    Ohmura E, Okada M, Onoda N, Kamiya Y, Murakami H, Tsushima T, Shizume K.
    Cancer Res; 1990 Jan 01; 50(1):103-7. PubMed ID: 2152769
    [Abstract] [Full Text] [Related]

  • 16. Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
    Hébert CD, Birnbaum LS.
    Cancer Res; 1989 Jun 15; 49(12):3196-202. PubMed ID: 2541899
    [Abstract] [Full Text] [Related]

  • 17. Novel action of transforming growth factor beta 1 in functioning human pancreatic carcinoid cells.
    Ishizuka J, Beauchamp RD, Sato K, Townsend CM, Thompson JC.
    J Cell Physiol; 1993 Jul 15; 156(1):112-8. PubMed ID: 8391003
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL, Tandon AK, Von Hoff DD, Osborne CK.
    Cancer Res; 1988 Jul 15; 48(14):3898-904. PubMed ID: 3164252
    [Abstract] [Full Text] [Related]

  • 19. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest.
    Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS.
    Oncogene; 2002 Feb 28; 21(10):1616-24. PubMed ID: 11896591
    [Abstract] [Full Text] [Related]

  • 20. Evidence that TGF-beta can inhibit human T-lymphocyte proliferation through paracrine and autocrine mechanisms.
    Fox FE, Ford HC, Douglas R, Cherian S, Nowell PC.
    Cell Immunol; 1993 Aug 28; 150(1):45-58. PubMed ID: 8393732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.